Masuda Takahiro, Iwamoto Shosuke, Yoshinaga Ryohei, Tozaki-Saitoh Hidetoshi, Nishiyama Akira, Mak Tak W, Tamura Tomohiko, Tsuda Makoto, Inoue Kazuhide
1] Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan [2] Core Research for Evolution Science and Technology, Japan Science and Technology Agency, Tokyo 102-0076, Japan.
Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Nat Commun. 2014 May 13;5:3771. doi: 10.1038/ncomms4771.
In response to neuronal injury or disease, microglia adopt distinct reactive phenotypes via the expression of different sets of genes. Spinal microglia expressing the purinergic P2X4 receptor (P2X4R) after peripheral nerve injury (PNI) are implicated in neuropathic pain. Here we show that interferon regulatory factor-5 (IRF5), which is induced in spinal microglia after PNI, is responsible for direct transcriptional control of P2X4R. Upon stimulation of microglia by fibronectin, IRF5 induced de novo expression of P2X4R by directly binding to the promoter region of the P2rx4 gene. Mice lacking Irf5 did not upregulate spinal P2X4R after PNI, and also exhibited substantial resistance to pain hypersensitivity. Furthermore, we found that expression of IRF5 in microglia is regulated by IRF8. Thus, an IRF8-IRF5 transcriptional axis may contribute to shifting spinal microglia toward a P2X4R-expressing reactive state after PNI. These results may provide a new target for treating neuropathic pain.
针对神经元损伤或疾病,小胶质细胞通过表达不同的基因集呈现出不同的反应性表型。外周神经损伤(PNI)后,脊髓中表达嘌呤能P2X4受体(P2X4R)的小胶质细胞与神经性疼痛有关。在这里,我们表明,PNI后在脊髓小胶质细胞中诱导产生的干扰素调节因子5(IRF5)负责对P2X4R进行直接转录调控。在用纤连蛋白刺激小胶质细胞后,IRF5通过直接结合P2rx4基因的启动子区域诱导P2X4R的从头表达。缺乏Irf5的小鼠在PNI后不会上调脊髓P2X4R,并且对疼痛超敏反应也具有显著抗性。此外,我们发现小胶质细胞中IRF5的表达受IRF8调控。因此,IRF8-IRF5转录轴可能有助于在PNI后使脊髓小胶质细胞转变为表达P2X4R的反应性状态。这些结果可能为治疗神经性疼痛提供新的靶点。